0000950170-24-106479.txt : 20240913 0000950170-24-106479.hdr.sgml : 20240913 20240913172008 ACCESSION NUMBER: 0000950170-24-106479 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240910 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20240913 DATE AS OF CHANGE: 20240913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KINETA, INC./DE CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37695 FILM NUMBER: 241298671 BUSINESS ADDRESS: STREET 1: 7683 SE 27TH STREET STREET 2: SUITE 481 CITY: MERCER ISLAND STATE: WA ZIP: 98040 BUSINESS PHONE: (206) 378-0400 MAIL ADDRESS: STREET 1: 7683 SE 27TH STREET STREET 2: SUITE 481 CITY: MERCER ISLAND STATE: WA ZIP: 98040 FORMER COMPANY: FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140813 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 8-K 1 ka-20240910.htm 8-K 8-K
false0001445283KINETA, INC./DENASDAQ00014452832024-09-102024-09-10

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 10, 2024

 

 

 

KINETA, INC.

 

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

001-37695

20-8436652

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

7683 SE 27th Street, Suite 481

 

 

Mercer Island, WA

 

98040

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (206) 378-0400

 

Not Applicable

 

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading

Name of each exchange

 

 

Symbol(s)

on which registered

 

Common Stock, par value $0.001 per share

 

KA

 

The Nasdaq Capital Market

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 1.01

Entry into a Material Definitive Agreement.

On September 13, 2024 (the “Effective Date”), Kineta, Inc. (the “Company”) entered into a Settlement Agreement (the “Agreement”) with ARE-SEATTLE No. 17, LLC (the “Landlord”), the landlord of the Company’s former premises in Seattle, Washington. Under the terms of the Agreement, the Company has agreed to pay the Landlord the outstanding monetary obligation of $679,210.42 (the “Outstanding Debt”) pursuant to that certain Lease Agreement, by and between the Company and the Landlord, dated as of November 19, 2010, as amended through June 30, 2020 (collectively, the “Lease”) as follows: (i) the Landlord’s application of the security deposit in the amount of $70,000, (ii) the Company’s payment to the Landlord of $85,000.00 (the “First Payment”) no later than five (5) business days after the Effective Date, and (iii) the Company’s payment to the Landlord of the Outstanding Debt balance of $524,210.42 (the “Second Payment” and together with the First Payment, the “Payment Milestones”) no later than February 1, 2025. The Agreement stipulates that upon the receipt by the Landlord of the Payment Milestones, the Landlord will fully discharge and forever release the Company from any claim, cause of action, or judgment, legal or equitable, in contract or tort, direct or indirect, presently asserted or not, known or unknown, through the date of the Agreement related to the Company’s monetary obligations under the Lease.

Additionally, under the Agreement, as consideration for the Landlord’s agreement to delay collection of the Outstanding Debt and to not assess additional interest and late fees with respect to the Outstanding Debt, the Company executed a Confession of Judgment (the “Confession”) in favor of the Landlord, and as consideration for the Company’s agreement to execute the Confession, the Landlord agreed not to file any lawsuit or other legal action against the Company related to the Outstanding Debt, or to otherwise cause the Confession to be entered into any legal action or proceeding unless the Company fails to satisfy the Payment Milestones. The Agreement specifies that except as it relates to the matters contemplated in the Agreement, no action by the parties is to be construed as an admission of liability by any party as it relates to such parties’ rights or obligations under the Lease.

The Company entered into the Agreement to avoid the costs and uncertainties of legal proceedings, reflecting the Company’s commitment to responsibly managing its financial obligations and disputes as it continues to explore strategic alternatives.

The foregoing description of the terms and conditions of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the period ending September 30, 2024.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The disclosure contained under Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein.

 

 

Item 3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Lack of Compliance with Bid Price Rule

As previously disclosed on a Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on April 18, 2024, the Company received a written notice on April 18, 2024 (the “Minimum Bid Notice”) from the Nasdaq Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”) because the Company had not maintained a minimum closing bid price of at least $1.00 per share for the last 30 consecutive business days prior to April 18, 2024. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days from the Minimum Bid Notice, or until October 15, 2024, to regain compliance with the Bid Price Rule, but the Company has so far failed to regain compliance with the Bid Price Rule and has not submitted a plan of compliance for an additional extension because the Company does not meet the compliance requirements of the Stockholders’ Equity Rule (as defined below).

Lack of Compliance with Stockholders’ Equity Rule

As previously disclosed on a Current Report on Form 8-K filed with the SEC on May 23, 2024, on May 23, 2024, the Company received a written notice (the “Stockholders’ Equity Notice”) from the Staff informing the Company that it no longer complies with the requirement under Nasdaq Listing Rule 5550(b)(1) to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on Nasdaq (the “Stockholders’ Equity Rule”), and, as of the date of the Stockholders’ Equity Notice, the Company did not meet the alternatives of market value of listed securities or net income from continuing operations. The Stockholders’ Equity Notice provided that the Company has 45 calendar days, or until July 8, 2024, to submit a plan to regain compliance. The Company timely submitted the compliance plan to the Staff on July 8, 2024 and submitted a further revised plan on August 5, 2024.

 

 

 

Nasdaq Determination Letter

On September 10, 2024, the Company received a determination letter (the “Letter”) from the Staff informing the Company that the Staff has reviewed the materials submitted by the Company and has determined to deny the Company’s request for continued listing on The Nasdaq Capital Market. The Letter noted that, as of the date of the Letter, the Company is not eligible for a second 180-day compliance period, expiring October 15, 2024, to comply with the Bid Price Rule and has not provided a plan to regain compliance with the Bid Price Rule by October 15, 2024. According to the Letter, the Staff has determined that the Company did not provide a definitive plan evidencing its ability to achieve near term compliance with the continued listing requirements or sustain such compliance over an extended period of time. Unless the Company requests an appeal of this determination before a Nasdaq Hearings Panel (the “Panel”) by September 17, 2024, trading of the Company’s currently listed securities would be suspended at the opening of business on September 19, 2024, and a Form 25-NSE would be filed with the SEC to remove the Company’s securities from listing and registration on the Nasdaq.

The Company intends to timely file the appeal and pay the required fee to initiate the appeal to the Panel. The hearing request will result in a stay of any suspension or delisting action pending the hearing. There can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will be able to evidence compliance prior to the expiration of any extension that may be granted by the Panel.

The Company’s common stock will continue to trade uninterrupted under the symbol “KA” on The Nasdaq Capital Market pending the Panel’s decision.

If the Company’s securities are delisted from The Nasdaq Capital Market, it could be more difficult to buy or sell the Company’s securities or to obtain accurate quotations, and the price of the Company’s securities could suffer a material decline. Delisting could also impair the Company’s ability to raise capital.

Cautionary Statements Regarding Forward-Looking Statements

This Current Report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The use of words such as, but not limited to, “believe,” “expect,” “estimate,” “project,” “intend,” “future,” “potential,” “continue,” “may,” “might,” “plan,” “will,” “should,” “seek,” “anticipate,” or “could” and other similar words or expressions are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements relating to the Company’s intention to present a plan to regain compliance with the Bid Price Rule and the Stockholders’ Equity Rule. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on the Company’s current beliefs, expectations and assumptions regarding the future of the Company’s business, future plans and strategies, and other future conditions. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.

Such forward-looking statements are subject to a number of material risks and uncertainties including, but not limited to: whether the Company will be able to pursue a strategic transaction, or whether any transaction, if pursued, will be completed on attractive terms or at all; whether the Company’s cash resources will be sufficient to fund its foreseeable and unforeseeable operating expenses and capital requirements; the Company’s ability to regain compliance with the Bid Price Rule and the Stockholders’ Equity Rule and those risks set forth under the caption “Risk Factors” in the Company’s Annual Report and Quarterly Reports as well as discussions of potential risks, uncertainties and other important factors in the Company’s subsequent filings with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Except as required by law, the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as result of new information, future events or otherwise.


 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 13, 2024

 

Kineta, Inc.

 

By:

/s/ Craig Philips

Name:

Craig Philips

Title:

President

 

 

 EX-101.SCH 2 ka-20240910.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Central Index Key Entity Central Index Key Entity Address, State or Province Entity Address, State or Province Cover [Abstract] Cover [Abstract] Entity Address, Address Line One Entity Address, Address Line One Amendment Flag Amendment Flag Entity Address, City or Town Entity Address, City or Town Document Type Document Type Title of 12(b) Security Security 12b Title Soliciting Material Soliciting Material Entity Address, Address Line Two Entity Address, Address Line Two Document Period End Date Document Period End Date Trading Symbol Trading Symbol Pre-commencement Tender Offer Pre Commencement Tender Offer Security Exchange Name Security Exchange Name Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Securities Act File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number City Area Code City Area Code Local Phone Number Local Phone Number XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Document and Entity Information
Sep. 10, 2024
Cover [Abstract]  
Entity Registrant Name KINETA, INC./DE
Amendment Flag false
Entity Central Index Key 0001445283
Document Type 8-K
Document Period End Date Sep. 10, 2024
Entity Incorporation State Country Code DE
Entity File Number 001-37695
Entity Tax Identification Number 20-8436652
Entity Address, Address Line One 7683 SE 27th Street
Entity Address, Address Line Two Suite 481
Entity Address, City or Town Mercer Island
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98040
City Area Code (206)
Local Phone Number 378-0400
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001 per share
Trading Symbol KA
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports ka-20240910.htm ka-20240910.xsd http://xbrl.sec.gov/dei/2024 false false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ka-20240910.htm": { "nsprefix": "ka", "nsuri": "http://www.kinetabio.com/20240910", "dts": { "inline": { "local": [ "ka-20240910.htm" ] }, "schema": { "local": [ "ka-20240910.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 4, "http://xbrl.sec.gov/dei/2024": 4 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 23 }, "report": { "R1": { "role": "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_c095c8b9-fde4-4c05-b9ac-cc8b2f4ae5b1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ka-20240910.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_c095c8b9-fde4-4c05-b9ac-cc8b2f4ae5b1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ka-20240910.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.kinetabio.com/20240910/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 13 0000950170-24-106479-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-106479-xbrl.zip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end XML 14 ka-20240910_htm.xml IDEA: XBRL DOCUMENT 0001445283 2024-09-10 2024-09-10 false 0001445283 KINETA, INC./DE NASDAQ 8-K 2024-09-10 DE 001-37695 20-8436652 7683 SE 27th Street Suite 481 Mercer Island WA 98040 (206) 378-0400 false false false false Common Stock, par value $0.001 per share KA false